Health Care & Life Sciences » Biotechnology | Proteon Therapeutics Inc.

Proteon Therapeutics Inc.

Proteon Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$1.14
Market Cap
$8.25 M
Shares Outstanding
19.59 M
Public Float
7.85 M

Profile

Address
200 West Street
Waltham Massachusetts 02451
United States
Employees -
Website http://www.proteontherapeutics.com
Updated 07/08/2019
Proteon Therapeutics, Inc. engages in the research and development of biopharmaceutical products. It produces and commercializes vonapanitase for the treatment of renal and vascular disease. The company was founded by F.

Financials

View All

Timothy P. Noyes
President, Chief Executive Officer & Director
Paul J. Hastings
Chairman